Clinical Trial Update: Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is exploring whether a Factor VIII/von Willebrand factor concentrate can induce immune tolerance in patients with Hemophilia A, assessi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• FVIII/VWF concentrate (Factor VIII/von Willebrand factor concentrate)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Hemophilia A | Phase 4 | Status: UNKNOWN